Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print

Financial Report: Charles River Laboratories



Published August 8, 2012
Charles River Laboratories
 
2Q Revenues: $284.7 million (-1%)

2Q Earnings: $30.6 million (-6%)

YTD Revenues: $570.7 million (flat)

YTD Earnings: $57.1 million (-11%)

Comments: Research Models and Services sales were $173.6 million in quarter (-3%). Foreign exchange impacted sales by 3.8%. Preclinical Services sales were $111.1 million (+1%). Foreign currency exchange reduced sales by 2.1%.
 


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On